Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • News

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • THE ICET-A RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF DISTURBANCES OF GLUCOSE HOMEOSTASIS IN THALASSEMIA MAJOR PATIENTS

    Vincenzo De Sanctis
    e2016058
    2016-10-25
    https://doi.org/10.4084/mjhid.2016.058
    4215
    PDF: 1196
    HTML: 1185
  • APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA

    Tadeusz Robak
    e2010011
    2010-05-07
    https://doi.org/10.4084/mjhid.2010.011
    1669
    PDF: 647
    HTML: 2433
  • HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA AND SICKLE CELL DISEASE: EXPERIENCE OF MEDITERRANEAN INSTITUTE OF HEMATOLOGY IN A MULTI-ETHNIC POPULATION.

    Marco Marziali, Antonella Isgrò, Javid Gaziev, Guido Lucarelli
    e2009027
    2009-12-26
    1673
    PDF: 723
    HTML: 2916
  • Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists

    Monica Carpenedo, Dr, Dr, Dr
    e2023021
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.021
    1188
    PDF: 1078
    HTML: 693
  • ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS

    Junyue Cao, YuChao Sun
    e2025060
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.060
    938
    PDF: 505
    Html: 144
    Suppl. Files: 174
  • CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION

    Rafael de la Camara
    e2016031
    2016-06-20
    https://doi.org/10.4084/mjhid.2016.031
    4812
    PDF: 1788
    HTML: 2707
    Untitled: 220
  • Effectiveness and Safety of Sitagliptin in Patients with Beta-thalassaemia Major and Diabetes Mellitus: A Case Series

    Shahrzad Zonoozi
    e2017004
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.004
    2936
    PDF: 987
    HTML: 1289
  • PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome

    Kalman Filanovsky, Michal Haran, Vita Mirkin, Andrei Braester, Olga Shevetz, Anfisa Stanevsky, Erica Sigler, Ekaterina Votinov, Yehudit Zalzman-Amir, Alain Berrebi, Atan Gross, Lev Shvidel
    e2020072
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.072
    1099
    PDF: 763
    HTML: 293
  • PREVENTION AND TREATMENT OF HEPATITIS VIRUS INFECTION IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS

    Suparno Chakrabarti, Somnath Mukherjee
    e2009017
    2009-12-10
    https://doi.org/10.4084/mjhid.2009.017
    808
    PDF: 561
    HTML: 2459
  • BRUTON’S TYROSINE KINASE (BTK) MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A CLINICAL VIEW.

    Stefano Molica
    e2025053
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.053
    1590
    PDF: 912
    HTML: 121
  • KINETICS AND ROLE OF PANCREATIC STONE PROTEIN AND MIDREGIONAL PROADRENOMEDULLIN AS PREDICTORS OF SEPSIS AND BACTEREMIA IN CHILDREN WITH HAEMATOLOGICAL MALIGNANCIES.

    Vasiliki Antari, Lemonia Skoura, Athanasios Tragiannidis, Emmanuel Hatzipantelis, Vasiliki-Rengina Tsinopoulou, Konstantina Papakonstantinou, Efthimia Protonotariou, Assimina Galli-Tsinopoulou
    e2023065
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.065
    890
    PDF: 721
    HTML: 117
  • ASSOCİATİON BETWEEN IRON OVERLOAD AND GLUCOSE METABOLİSM İN CHİLDREN AND YOUTH WİTH TRANSFUSİON-DEPENDENT BETA THALASSEMİA: THE ROLE OF CHELATİON THERAPY

    Deniz Guven, Dr. İncefidan, Dr. Kazanci, Dr. Ozlem Kara
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.017
    640
    PDF: 517
    HTML: 70
  • Isavuconazole successfully treated pulmonary mucormycosis in acute myeloid leukemia: A case report

    Hong Chen, Kun Chen, wenqiang kong
    e2025031
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.031
    848
    PDF: 738
    HTML: 81
  • PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis

    Fiorina Giona
    e2021069
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.069
    1850
    HTML: 1454
    PDF: 1088
  • Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia

    Massimo Breccia, Gioia Colafigli, Luisa Quattrocchi, elisabetta abruzzese, giuliana alimena
    e2016016
    2016-02-20
    https://doi.org/10.4084/mjhid.2016.016
    2917
    PDF: 691
    HTML: 1934
    figure 1: 169
    figure 2: 176
  • IN UTERO HAEMATOPOIETIC STEM CELL TRANSPLANTATION (IUHSCT)

    Maria Concetta Renda, Aurelio Maggio
    e2009031
    2009-12-29
    1062
    PDF: 456
    HTML: 899
  • EFFECTS OF DARATUMUMAB ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE PLANNED TO RECEIVE AUTOLOGOUS TRANSPLANTATION: WHAT’S THE RELEVANCE?

    Pellegrino Musto, Dr. Nicola Sgherza
    e2024073
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.073
    1518
    PDF: 805
    HTML: 155
  • EBV AND HIV-RELATED LYMPHOMA

    Michele Bibas, Andrea Antinori
    e2009032
    2009-12-29
    https://doi.org/10.4084/mjhid.2009.032
    1563
    PDF: 637
    HTML: 6860
  • Evaluation of Hepatitis B and C Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

    Nathalia Sena de Oliveira Silva, Gislaine Duarte, Samuel de Souza Medina, Guilherme Brasil Duffles Amarante, Carmino Antonio de Souza, Katia Borgia Barbosa Pagnano
    e2026001
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.001
    663
    PDF: 481
    Html: 79
  • Addition of daratumumab to first-line therapy of newly diagnosed multiple myeloma in patients eligible for autologous stem cell transplantation: a single-center real-life experience

    Edoardo Olivari
    e2025040
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.040
    1043
    PDF: 770
    HTML: 151
  • Counting the Cost: How Anticipating Financial Burden Affects Post-Traumatic Stress Symptoms in Patients Newly Diagnosed with Leukemia and Lymphoma

    Fabio Guolo, Paola Del Sette, Francesca Riccardi, Paola Minetto, Andrea Todiere, Filippo Ballerini, Carola Riva, Michele Cea, Roberto Massimo Lemoli, Elena Sarcletti
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.029
    423
    PDF: 342
    HTML: 73
  • H1N1 influenza among hematological patients: monocentric influenza cases from 2011 to 2016.

    Elisabetta Metafuni, Rosaria Santangelo, Patrizia Chiusolo, Luca Laurenti, Federica Sorà, Sabrina Giammarco, Simona Sica
    e2017024
    2017-03-01
    https://doi.org/10.4084/mjhid.2017.024
    1877
    PDF: 704
    HTML: 738
  • COST-EFFECTIVENESS OF POST-AUTOTRANSPLANT LENALIDOMIDE IN PERSONS WITH MULTIPLE MYELOMA.

    Monia Marchetti , Robert Peter Gale, Giovanni Barosi
    Page e2021034
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.034
    1436
    PDF: 517
    HTML: 183
  • DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA

    Sabina Chiaretti, Gina Zini, Renato Bassan
    e2014073
    2014-10-24
    https://doi.org/10.4084/mjhid.2014.073
    9080
    PDF: 6063
    HTML: 87963
    Fig.1b: 185
    Fig.1c: 190
    Fig.2a: 177
    Fig.2b: 177
    Fig.4: 188
    Fig.2c: 185
    Fig.3: 184
    Tab.1: 228
    Tab.2: 207
    Tab.3: 190
    Tab.4: 222
    Fig1a: 186
  • Possible treatment failure of artemether-lumefantrine in an Italian traveler with uncomplicated falciparum malaria.

    Ernestina Carla Repetto, Claudio Giacomazzi, Antonio Traverso
    e2011041
    2011-10-02
    https://doi.org/10.4084/mjhid.2011.041
    1765
    PDF: 659
    HTML: 3402
  • EBV IN HODGKIN LYMPHOMA

    Giuseppina Massini, Doerte Siemer, Stefan Hohaus
    e2009013
    https://doi.org/10.4084/mjhid.2009.013
    1659
    PDF: 601
    HTML: 13944
  • Severe CMV infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in an old mantle cell lymphoma patient

    Gabriele Magliano, Annarosa Cuccaro, Francesco D'Alo', Elena Maiolo, Silvia Bellesi, Stefan Hohaus, Andrea Bacigalupo, Livio Pagano
    e2021054
    2021-08-28
    https://doi.org/10.4084/MJHID.2021.054
    1225
    PDF: 400
    HTML: 158
  • The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY

    Sarah Liptrott, Mairéad NíChonghaile, Liz O'Connell, Erik Aerts
    e2023033
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.033
    1840
    Suppl. Files: 878
    HTML: 429
    PDF: 744
  • FIRST-PHASE INSULIN RESPONSE (FPIR) TO INTRAVENOUS GLUCOSE TOLERANCE TEST (IVGTT), INSULIN SENSITIVITY AND LONG-TERM FOLLOW-UP IN TRANSFUSION-DEPENDENT BETA-THALASSEMIA (TDT) NORMOGLYCEMIC PATIENTS WITH REDUCED INSULIN SECRETION TO ORAL GLUCOSE TOLERANCE TEST: A PILOT STUDY. The function of the endocrine pancreas in transfusion-dependent ?-thalassemia

    Vincenzo De Sanctis
    e2021021
    2021-02-26
    https://doi.org/10.4084/mjhid.2021.021
    7330
    PDF: 552
    HTML: 232
  • Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation

    Francesca Maria Quaglia, Gian Matteo Rigolin, Elena Saccenti, Massimo Negrini, Eleonora Volta, Melissa Dabusti, Maria Ciccone, Antonio Urso, Michele Laudisi, Antonio Cuneo
    e2019057
    2019-08-29
    https://doi.org/10.4084/mjhid.2019.057
    1563
    PDF: 961
    HTML: 250
  • CLINICAL IMPACT OF ELTROMBOPAG-ASSOCIATED IRON CHELATION IN ADULTS WITH IMMUNE THROMBOCYTOPENIA: A MULTICENTER REAL-WORLD STUDY

    Ahmet Yigitbasi, Elif Gulsum Umit, Ufuk Demirci, Guray Aygun, Nese Varli, Elif Aksoy, Fehmi Hindilerden, Emine Gulturk, Eren Arslan Davulcu, Ahmet Muzaffer Demir
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.027
    712
    PDF: 520
    HTML: 72
  • ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING

    Masafumi Taniwaki, Mihoko Yoshida, Yosuke Matsumoto, Kazuho Shimura, Junya Kuroda, Hiroto Kaneko
    e2018014
    2018-02-15
    https://doi.org/10.4084/mjhid.2018.014
    5266
    PDF: 1921
    HTML: 1360
  • PERCEPTION OF COMMUNITY HEALTH CARE WORKERS ABOUT PATIENTS WITH SICKLE CELL DISEASE IN PRIMARY HEALTH CARE AFTER AN EDUCATIONAL INTERVENTION

    Ludmila Mourão Xavier Gomes, Marcos Borato Viana, Igor Alcântara Pereira
    22015031
    2015-04-19
    https://doi.org/10.4084/mjhid.2015.031
    2080
    PDF: 961
    HTML: 1658
  • COINCIDENCE OR CONNECTION? REVISITING THE RELATIONSHIP BETWEEN MASTOCYTOSIS AND LYMPHOMA

    Antonio Frolli, Cristina Papayannidis, Carmen Fava, Martina Bullo, Selene Grano, Valentina Bonuomo, Daniela Gottardi, Guido Parvis, Beatrice Casadei, Daniela Cilloni
    e2026047
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.047
    177
    PDF: 189
    HTML: 11
  • Graves’ disease thyrotoxicosis and propylthiouracil related agranulocytosis successfully treated with therapeutic plasma exchange and g-csf followed by total thyroidectomy.

    Anna Candoni
    e2017058
    2017-10-16
    https://doi.org/10.4084/mjhid.2017.058
    2899
    PDF: 878
    HTML: 1411
    Fig.1: 164
    Fig.2: 173
  • ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES

    Daniel Olson, Abraham Tareq Yacoub, Gelenis Domingo, John Norman Greene
    e2014068
    2014-08-28
    https://doi.org/10.4084/mjhid.2014.068
    1837
    PDF: 718
    HTML: 2109
    Untitled: 218
    Untitled: 153
    Untitled: 172
    Untitled: 155
    Untitled: 164
    Untitled: 180
    Untitled: 185
  • Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients

    Gianmarco Bagnato, Vittorio Stefoni, Alessandro Broccoli, Lisa Argnani, Cinzia Pellegrini, Beatrice Casadei, Francesca Bonifazi, Pier Luigi Zinzani
    e2024004
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.004
    1433
    PDF: 1393
    HTML: 190
  • Sinopharm Vaccine, SARS-CoV-2 breakthrough infections and Hemoglobinopathies

    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
    e2022060
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.060
    701
    PDF: 457
    HTML: 204
  • HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases

    Donato Rigante, Helena Pelanda, Eleonora Rulli, Murad Sultanov, Susanna Adornato
    e2026025
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.025
    1039
    PDF: 655
    HTML: 78
  • Impact of Sars-CoV-2 prophylaxis with tixagevimab-cilgavimab in high-risk patients with B-cell malignancies: a single-center retrospective study.

    Giovanni Manfredi Assanto ,, Matteo Totaro , Poggiali Rebecca, Delli Paoli Adele, Annechini Giorgia, D’Elia Gianna Maria, Aji Francesco, Petrucci Luigi, Fazio Francesca, Del Giudice Ilaria, Martelli Maurizio, Micozzi Alessandra, Giuseppe Gentile
    e2023061
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.061
    802
    PDF: 415
    HTML: 117
  • A case of multiple myeloma in a patient in treatment for chronic lymphocytic leukemia

    Mario Biglietto, Ugo Coppetelli, Luciano Fiori, Martina Gherardini, Raffaele Maglione, Alessandro Pulsoni, Azzurra Anna Romeo
    e2025033
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.033
    878
    PDF: 706
    HTML: 185
  • FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells

    Eugenio Galli, Filippo Frioni, Tanja Malara, Enrico Attardi, Silvia Bellesi, Stefan Hohaus, Simona Sica, Federica Sorà, Patrizia Chiusolo
    e2024029
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.029
    955
    PDF: 1208
    HTML: 111
  • ON THE VERSATILITY OF VON WILLEBRAND FACTOR

    Antoine Rauch, Peter Lenting
    e2013046
    2013-07-10
    https://doi.org/10.4084/mjhid.2013.046
    2803
    PDF: 1116
    HTML: 11216
  • Adjuvant corticosteroid therapy in hepatosplenic candidiasis-related IRIS

    Cengiz Bayram, Ali Fettah, Nese Yarali, Abdurrahman Kara, Fatih Mehmet Azik, Betül Tavil, Bahattin Tunc
    e2012018
    2012-03-13
    https://doi.org/10.4084/mjhid.2012.018
    1624
    PDF: 808
    HTML: 1214
  • COMPARISON OF EMPIRIC ANTIBIOTIC ESCALATION THERAPY WITH VANCOMYCIN (VAN) VERSUS LINEZOLID (LIN) IN PATIENTS WITH FEBRILE NEUTROPENIA

    Karin Mayer, Nicolaus Hegge, Ernst Molitor, Peter Brossart, Corinna Hahn-Ast
    e2022032
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.032
    1036
    PDF: 539
    HTML: 208
  • PREGNANCY LOSS IN WOMEN WITH HIV IS NOT ASSOCIATED WITH HIV MARKERS: DATA FROM A NATIONAL STUDY IN ITALY, 2001-2018

    Marco Floridia, Giulia Masuelli, Beatrice Tassis, Enrica Tamburrini, Valeria Savasi, Matilde Sansone, Arsenio Spinillo, Giuseppina Liuzzi, Anna Degli Antoni, Serena Dalzero, Laura Franceschetti, Giuliana Simonazzi, Gianpaolo Maso, Daniela Francisci, Carmela Pinnetti, Marina Ravizza
    e2019050
    2019-08-29
    https://doi.org/10.4084/mjhid.2019.050
    1268
    PDF: 903
    HTML: 194
  • ADVANCES IN THE TREATMENT OF MALARIA

    Francesco Castelli, Lina Rachele Tomasoni, Alberto Matteelli
    e2012064
    2012-10-03
    https://doi.org/10.4084/mjhid.2012.064
    2851
    PDF: 1124
    HTML: 5992
  • Direct oral anticoagulants (DOACs) in the onco-hematologic patients

    Mario Biglietto, Silvio Ligia, Alessandro Laganà, Giovanni Manfredi Assanto, Martina Gherardini, Erminia Baldacci, Cristina Santoro, Antonio Chistolini
    e2025022
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.022
    1020
    PDF: 1008
    HTML: 106
  • CYTOKINE RESPONSE ASSOCIATED WITH HEPATITIS C VIRUS CLEARANCE IN HIV COINFECTED PATIENTS INITIATING PEG INTERFERON-? BASED THERAPY.

    Truong Tam Nguyen, Reihani Niloofar, Pierre-Alain Rubbo, Kuster Nils, Karine Bollore, Jacques Ducos, Georges-Philippe Pageaux, Jacques Reynes, Philippe Van de Perre, Edouard Tuaillon
    e2016003
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.003
    3130
    PDF: 913
    HTML: 2047
    Untitled: 176
  • FEASIBILITY AND OUTCOME OF FIRST-LINE AUTOTRANSPLANT-BASED TREATMENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS AGED > 65 YEARS: MONOCENTRIC RETROSPECTIVE REAL-WORLD ANALYSIS Outcomes of ASCT in NDMM elderly fit patients

    Paola Stefanoni, Monica Galli, Laura Paris, Alessandro Rambaldi, Nicola Pittalis, Gianluca Cavallaro, Chiara Pavoni
    e2024066
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.066
    1056
    PDF: 622
    Html: 155
201 - 250 of 257 items << < 1 2 3 4 5 6 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy